Active Biotech AB (OSTO:ACTI) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:ACTI Active Biotech AB OSTO:ACTI
26 GF Score
Price kr5.30
! 1 Warning Sign
View Full Analysis

What is Active Biotech AB Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

OSTO:ACTI
26GF Score
Active Biotech AB OSTO:ACTI
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Active Biotech AB Business Description

Other Exchanges 0GQU:UKBTP:Germany
Address Scheelevagen 22, P.O. Box 724, Lund, SWE, 223 63
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy. Its project portfolio includes both small orally active immunomodulatory molecules and antibody-based immunotherapy. Its pipeline products are: Tasquinimod, Laquinimod, and Naptumomab.
26GF Score

Get the complete analysis for OSTO:ACTI

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr5.30
Price